Company transitions from pure digital asset treasury model to operating infrastructure supporting digital asset and AI applications; plans to unlock value from LineaRx business unit
BNB Plus Corp. (OTCQB:BNBX)
New Directors Bring Institutional Finance, Digital Asset and Infrastructure Expertise to the Company
BNB Plus Corp. (OTCQB:BNBX) ("BNB Plus" or the "Company") today announced the appointment of three
BNB Plus Corp. (OTCQB:BNBX) ("BNB Plus" or the "Company") today announced that, in furtherance of its ongoing strategic review, it has reached a mutual agreement with Cypress Management, LLC and its
BNB Plus Corp. (NASDAQ:BNBX) ("BNB Plus" or the "Company") today announced that it has received a delisting determination from the Hearing Panel of the Nasdaq Stock Market LLC ("Nasdaq") as a
Silvermine Capital Leads New and Existing Investor Group in Partnership with GlobalStake to Support Strategic Review of Digital Asset and Biotechnology Businesses
Additional Commitments Expected with the Company
BNB Plus Corp. (NASDAQ:BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest
Company Treasury Exceeds $12 Million with Recently Implemented Active Yield Generation Strategy
Provides Nasdaq Listing Status Update
BNB Plus Corp. (NASDAQ:BNBX) ("BNB Plus" or the "Company"), a
Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the
Provides Updated on BNB Token Holdings and Operating Company Performance
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company") today announced that its biopharmaceutical subsidiary, LineaRx, Inc.
Digital Asset and Infrastructure Expert Joins Board to Support Strategic Growth and BNB Treasury Operations
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced the appointment of
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Digital Asset Virtual Conference, held January
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"),
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua
Acceleration of Multi-Year Customer Agreement Represents Largest LineaDNA Order in Company History
Company Expects to Ship over $1.5M of LineaDNA in 1HCY2026
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"),
Successful Production and Shipment of Approximately 5 Grams of LineaDNA
Shipment Value Exceeds $390,000
Additional Multi-Gram Deliveries Expected in First Half CY2026
BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the
